Moreover, overall survival was lower in patients with high expression of both TGF-β and IL6 than in those with low expression of TGF-β and IL6 in their glioma samples and in the TCGA database (Supplementary Figs. 6c, 7c). The gene discussed is IL6; the disease is glioma.